[1]Etminan N, Chang H S, Hackenberg K, et al. Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis[J]. JAMA Neurol, 2019, 76(5):588-597.
[2]Bortolato A, Simonato D, Feltracco P, et al. Continuous stellate ganglion block in delayed cerebral ischemia: a possible supplementary approach to traditional therapy?[J]. J Anaesthesiol Clin Pharmacol, 2020, 36(2):265-267.
[3]Macdonald R L, Schweizer T A. Spontaneous subarachnoid haemorrhage[J]. Lancet, 2017, 389(10069):655-666.
[4]Chan V, Lindsay P, McQuiggan J, et al. Declining admission and mortality rates for subarachnoid hemorrhage in Canada between 2004 and 2015[J]. Stroke, 2019, 50(1):181-184.
[5]Connolly E S, Jr, Rabinstein A A, Carhuapoma J R, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2012, 43(6):1711-1737.
[6]Daou B J, Koduri S, Thompson B G, et al. Clinical and experimental aspects of aneurysmal subarachnoid hemorrhage[J]. CNS Neurosci Ther, 2019, 25(10):1096-1112.
[7]Brami J, Chousterman B, Boulouis G, et al. Delayed cerebral infarction is systematically associated with a cerebral vasospasm of large intracranial arteries[J]. Neurosurgery, 2020, 86(2):E175-E183.
[8]Osgood M L. Aneurysmal subarachnoid hemorrhage: review of the pathophysiology and management strategies[J]. Curr Neurol Neurosci Rep, 2021, 21(9):50.
[9]Takemoto Y, Hasegawa Y, Hayashi K, et al. The stabilization of central sympathetic nerve activation by renal denervation prevents cerebral vasospasm after subarachnoid hemorrhage in rats[J]. Transl Stroke Res, 2020, 11(3):528-540.
[10]Muhammad S, Hnggi D. Inflammation and anti-inflammatory targets after aneurysmal subarachnoid hemorrhage[J]. Int J Mol Sci, 2021, 22(14):7355.
[11]胡晓芳, 袁笑, 王玉红, 等. IL-6在蛛网膜下腔出血后脑血管痉挛发病机制中作用的研究[J]. 国际检验医学杂志, 2012, 33(20):2474-2477.
[12]Geraghty J R, Lung T J, Hirsch Y, et al. Systemic immune-inflammation index predicts delayed cerebral vasospasm after aneurysmal subarachnoid hemorrhage[J]. Neurosurgery, 2021, 89(6):1071-1079.
[13]Suzuki H, Fujimoto M, Kawakita F, et al. Toll-like receptor 4 and tenascin-C signaling in cerebral vasospasm and brain injuries after subarachnoid hemorrhage[J]. Acta Neurochir Suppl, 2020, 127: 91-96.
[14]沈伟, 余绍祖, 范华燕. 降钙素基因相关肽及内皮素在实验性蛛网膜下腔出血后急性与迟发性脑血管痉挛中的作用[J]. 临床神经病学杂志, 2003, 16(4):221-223.
[15]Cheng Y W, Li W J, Dou X J, et al. Role of endothelin-1 and its receptors in cerebral vasospasm following subarachnoid hemorrhage[J]. Mol Med Rep, 2018, 18(6):5229-5236.
[16]王旭, 屈伸, 万定, 等. 连续星状神经节阻滞预防颅内动脉瘤介入术后患者脑血管痉挛的效果[J]. 中华麻醉学杂志, 2017, 37(1):43-46.
[17]王士强, 张颖, 陈奇宏, 等. SGB对aSAH患者介入术后认知功能和血管痉挛的影响[J]. 西南国防医药, 2018, 28(9):812-814.
[18]王士强, 张颖, 曹阳, 等. 星状神经节阻滞对动脉瘤性蛛网膜下腔出血介入手术脑血管痉挛的防治[J]. 心脑血管病防治, 2018, 18(5):385-387.
[19]饶伟, 周超, 王士强. 连续星状神经节阻滞对颅内动脉瘤介入术后脑血管痉挛的治疗作用[J]. 介入放射学杂志, 2019, 28(1):15-18.
[20]张颖, 王士强, 李江飞. 星状神经节阻滞对动脉瘤性蛛网膜下腔出血介入治疗患者血管痉挛发生率及血清S100B蛋白水平的影响[J]. 贵州医药, 2019, 43(1):49-51.
[21]Wendel C, Scheibe R, Wagner S, et al. Decrease of blood flow velocity in the middle cerebral artery after stellate ganglion block following aneurysmal subarachnoid hemorrhage: a potential vasospasm treatment?[J]. J Neurosurg, 2019, 133(3):773-779.
[22]Zhang J, Nie Y, Pang Q N, et al. Effects of stellate ganglion block on early brain injury in patients with subarachnoid hemorrhage: a randomised control trial[J]. BMC Anesthesiol, 2021, 21(1):23.
[23]Pileggi M, Mosimann P J, Isalberti M, et al. Stellate ganglion block combined with intra-arterial treatment: a “one-stop shop” for cerebral vasospasm after aneurysmal subarachnoid hemorrhage—a pilot study[J]. Neuroradiology, 2021, 63(10):1701-1708.
[24]Samagh N, Panda N B, Gupta V, et al. Impact of stellate ganglion block in the management of cerebral vasospasm: a prospective interventional study[J]. Neurol India, 2022, 70(1):289-295.
[25]Davis J, Ozcan M S, Kamdar J K, et al. Stellate ganglion block used to treat reversible cerebral vasoconstriction syndrome[J]. Reg Anesth Pain Med, 2021, 46(8):732-734.
[26]Wang W W, Shi W D, Qian H, et al. Stellate ganglion block attenuates chronic stress induced depression in rats[J]. PLoS One, 2017, 12(8):e0183995.
[27]Chen Y Q, Xie Y Y, Wang B, et al. Effect of stellate ganglion block on hemodynamics and stress responses during CO2-pneumoperitoneum in elderly patients[J]. J Clin Anesth, 2017, 37: 149-153.
[28]Yang X, Shi Z, Li X, et al. Impacts of stellate ganglion block on plasma NF-κB and inflammatory factors of TBI patients[J]. Int J Clin Exp Med, 2015, 8(9):15630-15638.
[29]Flynn L M C, Begg C J, Macleod M R, et al. Alpha calcitonin gene-related peptide increases cerebral vessel diameter in animal models of subarachnoid hemorrhage: a systematic review and meta-analysis[J]. Front Neurol, 2017, 8: 357.
[30]毛琦, 张炳东, 陈燕桦, 等. 星状神经节阻滞对体外循环大鼠血浆及海马ET-1、CGRP的影响[J]. 山东医药, 2016, 56(6):22-24.
|